Valuation: Harbin Gloria Pharmaceuticals Co., Ltd

Market Cap 6.6B 972M 850M 781M 728M 1.38B 92.59B 1.4B 9.38B 3.65B 45.51B 3.65B 3.57B 157B P/E 2024
24.2x
P/E 2025 18.2x
Enterprise Value 5.76B 849M 742M 682M 636M 1.21B 80.83B 1.22B 8.19B 3.18B 39.73B 3.19B 3.12B 137B EV / Sales 2024
2.12x
EV / Sales 2025 2.82x
Free-Float
90.63%
Yield 2024 *
-
Yield 2025 -
1 day+0.68%
1 week+21.81%
Current month+9.63%
1 month+3.86%
3 months-20.43%
6 months-3.58%
Current year-3.58%
1 week 2.37
Extreme 2.37
3.01
1 month 2.37
Extreme 2.37
3.01
Current year 2.37
Extreme 2.37
3.99
1 year 2.37
Extreme 2.37
4.08
3 years 1.66
Extreme 1.66
4.08
5 years 1.66
Extreme 1.66
4.08
10 years 1.66
Extreme 1.66
9.8
Manager TitleAgeSince
Chief Executive Officer 53 26/12/2022
Corporate Officer/Principal 42 18/04/2018
Corporate Officer/Principal 40 23/05/2019
Director TitleAgeSince
Director/Board Member 53 11/11/2022
Director/Board Member 40 14/03/2025
Chairman 47 06/02/2025
Date Insider Type Main position Quantity % Market Cap.
02/07/25Sell 587,500 0.0283%
02/07/25Sell

Director

259,600 0.0125%
02/07/25Sell 587,500 0.0283%
Change 5-day change 1-year change 3-year change Capi.($)
+0.68%+21.81%+0.68%+39.62% 972M
+1.81%+2.25%+13.63%+81.62% 48B
-2.54%+3.72%+66.86%+116.52% 36.89B
+0.15%+1.26%-3.64%+44.11% 12.37B
+3.71%+3.56%+13.95%+98.68% 11.95B
+0.39%+0.58%+32.90%+120.94% 9.01B
+0.66%-0.57%+19.74%+46.69% 7.2B
+0.71%+1.75%+52.67%-6.28% 7.05B
+9.99%+32.94%-15.50%+25.64% 6.58B
+0.68%+2.63%+20.79%+240.34% 6.55B
Average +1.62%+4.90%+20.21%+80.79% 14.66B
Weighted average by Cap. +0.84%+3.40%+27.88%+89.41%

Financials

2024 2025
Net sales 2.44B 360M 314M 289M 269M 511M 34.24B 518M 3.47B 1.35B 16.83B 1.35B 1.32B 57.99B 2.14B 315M 275M 253M 236M 447M 29.95B 454M 3.03B 1.18B 14.72B 1.18B 1.16B 50.74B
Net income 233M 34.29M 29.98M 27.55M 25.68M 48.71M 3.27B 49.44M 331M 129M 1.6B 129M 126M 5.53B 377M 55.53M 48.54M 44.61M 41.58M 78.87M 5.29B 80.07M 536M 208M 2.6B 208M 204M 8.96B
Net Debt -509M -74.94M -65.51M -60.21M -56.12M -106M -7.14B -108M -723M -281M -3.51B -281M -275M -12.09B -838M -123M -108M -99.19M -92.46M -175M -11.76B -178M -1.19B -463M -5.78B -463M -453M -19.91B
Logo Harbin Gloria Pharmaceuticals Co., Ltd
HARBIN GLORIA PHARMACEUTICALS Co Ltd is a China-based company principally engaged in the research, development, production and sale of pharmaceuticals. The Company operates its businesses through three segments. The Traditional Chinese Medicine segment's main product is Annao Pills and Tablets. The Chemical Pharmaceuticals segment's products include cardiovascular and cerebrovascular drugs, musculoskeletal drugs, vitamins, electrolytes, analgesics, anti-infectives, anti-tumor drugs and others. The Others segment engages in pharmaceutical research and development, clinical services and others. The Company distributes its products within the domestic market and to overseas markets.
Employees
2,350
Date Price Change Volume
03/07/26 CN¥2.960 +0.68% 111,111,183
02/07/26 CN¥2.940 +2.08% 156,631,562
01/07/26 CN¥2.880 +6.67% 177,588,364
30/06/26 CN¥2.700 +1.12% 149,822,287
29/06/26 CN¥2.670 +9.88% 117,194,764

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002437 Stock